Indication
Myocardial Injury
7 clinical trials
13 products
1 drug
Product
TADClinical trial
Multicenter, Randomized, Double-blind, Phase III Study of Intravenous TAD® 600 mg/4 mL Solution for Injection to Evaluate Efficacy and Safety in Preventing Myocardial Injury in Patients With Pneumonia.Status: Not yet recruiting, Estimated PCD: 2024-09-30
Product
Saline solutionProduct
Saline solution 0.9%Product
Saline SolutionClinical trial
Glucagon-like Peptide-1 Receptor Agonist for Reduction of Myocardial Injury After Non-Cardiac SurgeryStatus: Not yet recruiting, Estimated PCD: 2026-12-31
Product
SemaglutideClinical trial
Cardioprotective Effects of Cardiopeptides for Injection in Patients With Non-severe Cardiac Disease: a Single-center Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2023-11-25
Product
CardiopeptidesClinical trial
Pulse Glucocorticoid Therapy in Patients With ST-Segment Elevation Myocardial InfarctionStatus: Active (not recruiting), Estimated PCD: 2024-01-30
Product
MethylprednisoloneProduct
Isotonic salineClinical trial
Effect of Remote Ischemic Preconditioning in Patients Undergoing On-pump Coronary Artery Bypass Graft Surgery With Crystalloid Cardioplegic ArrestStatus: Completed, Estimated PCD: 2018-03-01
Clinical trial
NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury (NACAM) TrialStatus: Recruiting, Estimated PCD: 2025-04-30
Product
NiacinamideDrug
VarlilumabClinical trial
Effects of Low-dose Esmolol on Myocardial Injury After Non-cardiac Surgery in Elderly Frail Patients:A Multicenter, Prospective, Double-blind, Randomized Controlled StudyStatus: Recruiting, Estimated PCD: 2026-11-30
Product
EsmololProduct
Placebo Comparator